A Comparative Study On The Application Of TIVAP And PICC In Intravenous Chemotherapy Of Breast Cancer Patients

Objective:To investigate the clinical effect of Totally Implantable Venous Access Port(TIVAP)and Peripherally Inserted Central Catheter(PICC)in the intravenous chemotherapy of breast cancer patients,and to providereference for the selection of ideal intravenous infusion toelsfor breast cancer patients receiving chemotherapy.Methods:The case data of breast cancer patients who received chemotherapy in the Thyroid and Breast Surgery Department of theAffiliatedHospitalofNorthSichuanMedicalCollegefromMarch 1,2021 to September 30,2021 were retrospectively analyzed.A total of 180 patients were included,including 90 patients who voluntarily chose to have TIVAP implanted through the upper arm,and 90 patients who voluntarily chose to have PICC implanted through the upper arm.The incidence of complications,the difference in economic costs,and patients’ satisfaction with the route of intravenous chemotherapy were compared.Results:During the catheter indwelling period,the total incidence of complications in the TIVAP group was lower than that in the PICC group,and the difference was statistically significant(P<0.05).The average daily catheter maintenance cost in the TIVAP group was lower than that in the PICC group,and the difference was statistically significant(P<0.001).The satisfaction rate of the patients in the TIVAP group on the route of intra venous chemotherapy was significantly higher than that in the PICC group,and the difference was statistically significant(P<0.05).Conclusion:Compared with PICC,TIVAP has the advantages of fewer complications during use,lower maintenance costs,less impact on patients’daily life,and higher patient satisfaction.When conditions permit,it is recommended that breast cancer patients prefer TIVAP as an infusion tool for intravenous chemotherapy.